← Leaderboards
Chris Whitfield
Univ Of North Carolina Chapel Hill
$920,606
Attributed
$1,841,211
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $482.6K · FY2020–23$500K$375K$250K$125K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$1,841,211 · 1
By mechanism
R01$1,841,211 · 1
Top collaborators
- Virginia L Miller4 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Brian K. Shoichet$34,511,792
- David S Weiss$16,596,967
- Gauri G Rao$3,917,013
- Miriam S. Braunstein$8,640,200
- Jenny P.y. Ting$81,674,016
Others in their field
Other Emerging Leaders on “In Vivo”
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,216,744
- Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
- John Damon Chodera · Sloan-Kettering Inst Can Research$43,427,103
- Tony Moody · Duke University$34,777,314
- Alan D. Palkowitz · Indiana University Indianapolis$18,925,366
Research focus
In VivoIn VitroAntibiotic ResistanceImmunocompromised HostCarbapenemsInfectionCharacteristicsCarbapenem ResistanceColistin ResistanceCarbapenem-Resistant EnterobacteriaceaeComplementDefectCapsuleAffectEnterobacteriaceaeExtended-Spectrum î²-LactamaseExtracellularGene ExpressionGenesGenetic TranscriptionGram-Negative BacteriaCommunitiesHuman DiseaseKlebsiella